🇺🇸 FDA
Pipeline program

Tetrahydrocannabinol

Cannapremed-HMO-CTIL

Phase 3 small_molecule active

Quick answer

Tetrahydrocannabinol for Pain, Postoperative is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Pain, Postoperative
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials